Objective  To understand the cognition status of high-alert medications among medical staffs in Chongming District of Shanghai, and to explore its influencing factors and improvement countermeasures, so as to provide references for safe clinical use and effective control of such drugs.

Methods  Convenient sampling method was used to investigate among medical staffs in 9 hospitals in Chongming District from March to May 2022, the survey content included general information of medical staff and their awareness of high-alert medications. The orderly multi-classification logistic regression was used to analyze the influencing factors of the cognition of high-alert medications among medical staffs.

Results  A total of 605 valid questionnaires were collected, including 263 from doctors and 342 from nurses. The results of univariate analysis showed that there were significant differences in the grade distribution of high-alert medications management knowledge scores among doctors of different gender, education background and whether to partcipate in in-hospital training (P<0.05). There were significant differences in the grade distribution of high-alert medications management knowledge scores among nurses with different education background, hospital level and whether to partcipate in in-hospital training (P<0.05). There was significant differences in the grade distribution of high-alert medications pharmacy knowledge  scores whether doctors participated in in-hospital training (P<0.05). There were significant differences in the grade distribution of high-alert medications pharmacy knowledge scores among nurses with different education background, professional title, working years and whether to partcipate in in-hospital training (P<0.05). The results of multi-factor Logistic analysis showed that whether doctors had participated in in-hospital training was an influential factor for and high-alert medications management knowledge score level (OR=0.003, 95%CI 0.000 to 0.023, P<0.001), high-alert medications pharmacy knowledge score level (OR=0.252, 95%CI 0.147 to 0.431, P<0.001). Whether nurses participated in in-hospital training (OR=0.022, 95%CI 0.010 to 0.048, P<0.001) and hospital level (OR=3.353, 95%CI 1.639 to 6.855, P=0.001) were the influencing factors of nurses' high-alert medications management knowledge score level, and education background (OR=4.933, 95%CI 1.452 to 16.760, P=0.011) and whether nurses participated in in-hospital training (OR=0.414, 95%CI 0.239 to 0.717, P=0.002) were the influencing factors of nurses' high-alert medications pharmacy knowledge score level.

Conclusion  The cognition of high-alert medications among medical staffs in Chongming District is at a medium level on the whole. It is suggested to improve their cognitive ability and risk prevention awareness by improving their education, strengthening the knowledge education and training of high-alert medications, and homogenizing management, so as to ensure the safety of clinical drugs.

1.中国医药教育协会高警示药品管理专业委员会, 中国药学会医院药学专业委员会, 中国药理学会药源性疾病学专业委员会. 中国高警示药品临床使用与管理专家共识(2017)[J]. 药物不良反应杂志, 2017, 19(6): 409-413. DOI: 10.3760/cma.j.issn.1008-5734.2017.06.003.

2.李璇, 濮润, 于志伟, 等. 国外与中国台湾地区医疗机构高危药品风险因素与管理研究进展[J]. 药物流行病学杂志, 2014, 23(3): 159-162. [Li X, Pu R, Yu ZW, et al. Research progress on high-risk medications management in abroad and China's Taiwan region[J]. Chinese Journal of Pharmacoepidemiology, 2014, 23(3): 159-162.] DOI: 10.19960/j.cnki.issn1005-0698.2014.03.009.

3.王秀琴, 闫荟, 孙世光, 主编. 高警示药品管理学[M]. 北京: 中国科学技术出版社, 2017: 1-266.

4.中国医院协会. 中国医院协会发布《患者安全目标》(2019版)[EB/OL]. (2019-06-06)[2021-08-22]. http://www.cha.org.cn/plus/view.php?aid=15808.

5.程序, 卢今, 程希, 等. PDCA循环法在高警示药品管理中的应用[J]. 中国临床药学杂志, 2021, 30(5): 345-350. [Cheng X, Lu J, Cheng X, et al. Application of PDCA cycle method in high-alert medication management[J]. Chinese Journal of Clinical Pharmacy, 2021, 30(5): 345-350.] DOI: 10.19577/j.1007-4406.2021.05.006.

6.郑卫军,何凡. 现况调查的样本量计算方法[J]. 预防医学, 2020, 32(6): 647-648. [Zheng WJ, He F. Method of sample size calculation for current situation survey[J]. Journal of Preventive Medicine, 2020, 32(6): 647-648.] DOI: 10.19485/j.cnki.issn2096-5087.2020.06.028.

7.云南省药事管理及临床药学质量控制中心, 云南省急诊医学质量控制中心, 云南省护理学会, 等. 云南省高浓度氯化钾注射液临床使用与管理专家共识(2020) [J]. 中国药房, 2021, 32(2): 129-132. DOI: 10.6039/j.issn. 1001-0408.2021.02.01.

8.中国医师协会心血管内科医师分会心力衰竭学组, 中国医师协会急诊医师分会循环与血流动力学学组, 中国老年医学会心电与心功能分会. 多巴胺药物临床应用中国专家共识[J]. 中华医学杂志, 2021, 101(20): 1503-1512. DOI: 10.3760/cma.j.cn112137-20210328-00758.

9.湖北省抗癌协会癌症康复与姑息治疗专业委员会. 芬太尼透皮贴剂临床合理用药指南[J]. 医药导报, 2021, 40(11): 1463-1474. DOI: 10.3870/j.issn.1004-0781. 2021.11.001.

10.韦磊, 王绚. 某三级甲等儿童医院医务人员对高警示药品的认知现状及影响因素分析[J]. 安徽医学, 2021, 42(3): 332-335. [Wei L, Wang X. Analysis of the status quo and influencing factors of medical staff's cognition of high alert medication in a third-class A children's hospital[J]. Anhui Medical Journal, 2021, 42(3): 332-335.] DOI: 10.3969/j.issn.1000-0399.2021.03.025.

11.张瑶, 申良荣. 陕西省6所学校护生临床实习岗前高危药品知识认知现状调查[J]. 卫生职业教育, 2019, 37(3): 130-132. [Zhang Y, Shen LR. Investigation on knowledge cognition of high alert medication before clinical practice among nursing students in 6 schools in Shaanxi Province[J].Health Vocational Education, 2019, 37(3): 130-132.] DOI: CNKI:SUN:ZDYX.0.2019-03-074.

12.许敏, 吴静, 胡娟. 妇幼专科医院急诊科护士对静脉输注高警示药物认知现状调查[J]. 中国实用护理杂志, 2021, 37(16): 1206-1212. [Xu M, Wu J, Hu J. Investigation on cognitive status of emergency nurses on intravenous infusion of  high-alert drugs in maternal and child hospital[J]. Chinese Journal of Practical Nursing, 2021, 37(16): 1206-1212.] DOI: 10.3760/cma.j.cn211501-20200618-02812.

13.吴静, 李倩芸, 许敏. 妇幼专科医院急诊护士对静脉输注高警示药品的知信行调查[J]. 中国医药导报, 2022, 19(15): 75-78, 82. [Wu J, Li QY, Xu M. Investigation on knowledge, behavior, practice of emergency nurses in maternal and child specialty hospitals on intravenous infusion of high-alert drugs[J]. China Medical Herald, 2022, 19(15): 75-78, 82.] http://qikan.cqvip.com/Qikan/Article/Detail?id=7107299811.

14.Tang SF, Wang X, Zhang Y, et al. Analysis of high alert medication knowledge of medical staff in Tianjin: a convenient sampling survey in China[J]. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(2): 176-182. DOI: 10.1007/s11596-015-1407-4.

15.He M, Huang Q, Lu H, et al. Call for decision support for high-alert medication administration among pediatric nurses: findings from a large, multicenter, cross-sectional survey in China[J]. Front Pharmacol, 2022, 13: 860438. DOI: 10.3389/fphar.2022.860438.

16.Zyoud SH, Khaled SM, Kawasmi BM, et al. Knowledge about the administration and regulation of high alert  medications among nurses in Palestine: a cross-sectional study[J]. BMC Nurs, 2019, 18: 11. DOI: 10.1186/s12912-019-0336-0.

17.合理用药国际网络中国中心组临床安全用药组, 中国药理学会药源性疾病学专业委员会, 中国药学会医院药学专业委员会, 等. 高警示药品用药错误防范技术指导原则[J]. 药物不良反应杂志, 2017, 19(6): 403-408. DOI: 10.3760/cma.j.issn.1008-5734.2017.06.002.

18.杨燕, 姜剑飞, 崔志明, 等. 某院医务人员高危药品认知调查[J]. 中华医院管理杂志, 2012, 28(9): 690-694. [Yang Y, Jiang JF, Cui ZM, et al.Cognition survey of high-alert medication among medical staff in a hospital[J]. Chinese Journal of Hospital Administration, 2012, 28(9): 690-694.] DOI: 10.3760/cma.j.issn.1000-6672.2012.09.015.

19.中国医药教育协会. 医疗机构高警示药品风险管理规范[EB/OL]. (2023-09-28) [2023-10-15]. https://www.zzrmyy.com/Userfiles/file/20230928/6383151637605936196826611.pdf.

20.Schepel L, Lehtonen L, Airaksinen M, et al. How to identify organizational high-alert medications[J]. J Patient Saf, 2021, 17(8): e1358-e1363. DOI: 10.1097/PTS.0000000000000512.

21.刘芳, 张婷, 张晓乐, 等. 基于专家共识和医务人员调查的高警示药品目录建立[J]. 中国药学杂志, 2018, 53(17): 1523-1528. [Liu F, Zhang T, Zhang XL, et al. Development of high-alert medication list based on expert consensus and healthcare workers investigation[J]. Chinese Pharmaceutical Journal, 2018, 53(17): 1523-1528.] DOI: 10.11669/cpj.2018.17.018.

22.王娜, 张抗怀. 关于医疗机构药物警戒体系建设实践与思考[J]. 药物流行病学杂志, 2023, 32(11): 1217-1224. [Wang N, Zhang KH. Practice and reflection of pharmacovigilance system construction[J]. Chinese Journal of Pharmacoepidemiology, 2023, 32(11): 1217-1224.] DOI: 10.19960/j.issn.1005-0698.202311003.

23.樊迪, 孙倩雯, 贾富平, 等. 利用信息化技术加强高警示药品风险控制研究[J]. 药物流行病学杂志, 2016, 25(4): 254-257. [Fan D, Sun QW,Jia FP,et al. Using information technology to strengthen control the risk of high-alert medication[J]. Chinese Journal of Pharmacoepidemiology, 2016, 25(4): 254-257.] DOI: 1005-0698(2016)04-0254-04.

24.江贺春, 倪伟健, 伍章保. 我院高警示药品管理及风险控制[J]. 中国药房, 2021, 32(9): 1108-1113. [Jiang HC, Ni WJ, Wu ZB. High-alert drug management and risk control in our hospital[J]. China Pharmacy, 2021, 32(9): 1108-1113.] DOI: 10.6039/j.issn.1001-0408.2021.09.14.

25.Sullivan KM, Le PL, Ditoro MJ, et al. Enhancing high alert medication knowledge among pharmacy, nursing, and medical staff[J]. J Patient Saf, 2021, 17(4): 311-315. DOI: 10.1097/PTS.0b013e3182878113.

26.刘秀兰, 付伟, 刘东, 等. 2020年湖北省二级以上医疗机构药事管理质量控制指标实施现状调研[J]. 中国药师, 2022, 25(4): 682-687. [Liu XL, FuW, Liu D, et al. Investigation and analysis of the implementation status of pharmaceutical administration indicators in medical institutions above the secondary level in Hubei province in 2020[J]. China Pharmacist, 2022, 25(4): 682-687.] DOI: 10.19962/j.cnki.issn1008-049X.2022.04.022.